跳至主要内容
临床试验/SLCTR/2017/007
SLCTR/2017/007招募中未知

Effect of combination therapy of Pegylated interferon- Alpha 2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks on viral loads in Hepatitis C Virus (HCV) Genotype 3 chronic hepatitis & compensated cirrhosis patients

Department of Hepatology Bangabandhu Sheikh Mujib Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age more than 18 years
  • 2. Hepatitis C Virus (HCV) genotype 3
  • 3. Chronic hepatitis/ Compensated Cirrhosis
  • 4. Detectable HCV RNA in blood
  • 5. Platelet count >90,000 /cmm

排除标准

  • 1. Decompensated cirrhosis
  • 2. Co-infected with Hepatitis B Virus (HBV) or Human Immunodeficiency Virus (HIV)
  • 3. Hepatocellular carcinoma
  • 4. Pregnancy

研究者

发起方
Department of Hepatology Bangabandhu Sheikh Mujib Medical University

相似试验